Organon Q1 revenue falls 7% to $1.513 billion; dividend cut to $0.02 from $0.28
Organon reported first-quarter 2025 revenue of $1.513 billion, down 7%, and net income of $87 million, down 57% from a year earlier, while reaffirming its full-year 2025 guidance. The company also cut its quarterly dividend to $0.02 per share from $0.28 to accelerate debt reduction, a major change for shareholders who receive that payout.
Key points
- Q1 2025 revenue was $1.513 billion versus $1.622 billion in Q1 2024; diluted EPS was $0.33 versus $0.78.
- Quarterly dividend revised to $0.02 per share from $0.28, payable June 12, 2025, to holders of record on May 12, 2025.
- Full-year 2025 revenue guidance of $6.125 billion to $6.325 billion and Adjusted EBITDA margin guidance of 31.0% to 32.0% were left unchanged.
- As of March 31, 2025, cash and cash equivalents were $547 million and debt was $8.96 billion.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:38 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 01, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.